| Miss Amabel Catabay Hernandez, | |
|
7929 Lower Sacramento Rd, Stockton, CA 95210-3723 | |
| (209) 474-0880 | |
| Not Available |
| Full Name | Miss Amabel Catabay Hernandez |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 7929 Lower Sacramento Rd, Stockton, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326322413 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 64215 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Amabel Catabay Hernandez, 7929 Lower Sacramento Rd, Stockton, CA 95210-3723 Ph: () - | Miss Amabel Catabay Hernandez, 7929 Lower Sacramento Rd, Stockton, CA 95210-3723 Ph: (209) 474-0880 |
News Archive
When medication is used to shut off the oxygen supply to tumor cells, the cells adapt their metabolism in the medium term - by switching over to producing energy without oxygen. This observation by biomedical scientists at the University of Basel and University Hospital Basel could be used for treatments that can inhibit tumor growth in the long term, as the researchers report in the latest issue of the journal Cell Reports.
The federal Food and Drug Administration has approved a new, scalpel-free treatment for tremor in patients with medication-resistant Parkinson's disease.
Angiogenesis is a common process that is essential for tumor growth beyond 2 mm. Although numerous growth factors are involved, vascular endothelial growth factor (VEGF), particularly VEGF-A, has been shown to play an important role in tumor angiogenesis.
Cancer Research UK scientists have shown that screening for prostate cancer using prostate specific antigen (PSA) would lead to a substantial number of tumours diagnosed at an earlier and more treatable stage.
CytRx Corporation, a biopharmaceutical company, today announced that the Tumor Biology Center, Freiburg, Germany, plans to initiate a Phase 2 clinical trial with CytRx's doxorubicin prodrug INNO-206 as a treatment for patients with advanced pancreatic cancer.
› Verified 4 days ago
Penny Gibbons Burke, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1212 N California St, Stockton, CA 95202 Phone: 209-468-8711 Fax: 209-468-8712 | |
Dr. Ree Tran, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1050 N Wilson Way, Stockton, CA 95205 Phone: 209-948-0950 | |
Linh N Dang, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1528 E Fremont St, Stockton, CA 95205 Phone: 209-467-7861 | |
Lalitkumar Sukhram Singh Rajora, PHARMD, MS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1801 E March Ln Ste B270, Stockton, CA 95210 Phone: 650-935-1275 | |
Dr. David C Norris, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6455 Pacific Ave, Stockton, CA 95207 Phone: 209-478-5062 | |
Joan Y Chang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1050 N Wilson Way, Stockton, CA 95205 Phone: 209-948-0950 | |
An Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7850 West Ln, Stockton, CA 95210 Phone: 209-475-9515 Fax: 209-473-9521 |